|
|
Post by mnholdem on Aug 28, 2018 21:04:02 GMT -5
|
|
|
|
Post by goyocafe on Aug 28, 2018 21:14:19 GMT -5
Enter stage right, Afrezza! |
|
|
|
Post by joeypotsandpans on Aug 28, 2018 21:15:12 GMT -5
Enter Cipla, no worry about, bacterial buildup, blunt re-used needles, leaving metal fragments behind, etc....and speaking of not leaving behind, no pediatrics should be left behind either when it comes to inhalable vs. obsolete and barbaric forms of insulin therapy. |
|
|
|
Post by tomtabb on Aug 29, 2018 0:06:16 GMT -5
I would imagine that reusing needles in India is likely due to affordability. Does their health system fund needles?
|
|
|
|
Post by brotherm1 on Aug 29, 2018 4:11:07 GMT -5
“Only 1% of people with diabetes require insulin therapy.“
This, from the article, is grossly incorrect.
|
|
|
|
Post by agedhippie on Aug 29, 2018 7:59:28 GMT -5
“Only 1% of people with diabetes require insulin therapy.“ This, from the article, is grossly incorrect. Since 20% of diabetics are Type 1 I think grossly incorrect is a fair assessment  |
|
|
|
Post by agedhippie on Aug 29, 2018 8:08:25 GMT -5
In my experience needle reuse happens because people cannot be bothered to swap the needle if they inject a lot (8 or 9 times a day). They just put the cover back on the needle and that's it. Personally I always swap the needle because I find after the third use they tend to hurt so it's easier just to swap.
|
|
|
|
Post by kite on Aug 29, 2018 8:11:29 GMT -5
This is a great article. Thank you for sharing!
Can someone email the author about Afrezza + Cipla? Perhaps they can write a follow-up article to this one!
|
|
